NO910828D0 - Preparat for behandling av erektil funksjonssvikt. - Google Patents

Preparat for behandling av erektil funksjonssvikt.

Info

Publication number
NO910828D0
NO910828D0 NO1991910828A NO910828A NO910828D0 NO 910828 D0 NO910828 D0 NO 910828D0 NO 1991910828 A NO1991910828 A NO 1991910828A NO 910828 A NO910828 A NO 910828A NO 910828 D0 NO910828 D0 NO 910828D0
Authority
NO
Norway
Prior art keywords
erective
preparation
treatment
functional failure
failure
Prior art date
Application number
NO1991910828A
Other languages
English (en)
Other versions
NO910828L (no
NO301046B1 (no
Inventor
Nils G Kock
Gerhard Lycke
Original Assignee
Amsu Ltd
Haggren Johan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20373202&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO910828(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amsu Ltd, Haggren Johan filed Critical Amsu Ltd
Publication of NO910828D0 publication Critical patent/NO910828D0/no
Publication of NO910828L publication Critical patent/NO910828L/no
Publication of NO301046B1 publication Critical patent/NO301046B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
NO910828A 1988-09-02 1991-03-01 Fremgangsmåte for fremstilling av preparat for behandling av erektil funksjonssvikt NO301046B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8803087A SE463851B (sv) 1988-09-02 1988-09-02 Komposition foer behandling av erektil dysfunktion via uretra
PCT/SE1989/000462 WO1990002545A1 (en) 1988-09-02 1989-09-01 Composition for the treatment of erectile dysfunction

Publications (3)

Publication Number Publication Date
NO910828D0 true NO910828D0 (no) 1991-03-01
NO910828L NO910828L (no) 1991-04-30
NO301046B1 NO301046B1 (no) 1997-09-08

Family

ID=20373202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910828A NO301046B1 (no) 1988-09-02 1991-03-01 Fremgangsmåte for fremstilling av preparat for behandling av erektil funksjonssvikt

Country Status (16)

Country Link
US (4) US5886039A (no)
EP (2) EP0357581B2 (no)
JP (1) JPH0791199B2 (no)
AU (1) AU638414B2 (no)
CA (1) CA1335346C (no)
DE (1) DE68907909T3 (no)
DK (1) DK175560B1 (no)
ES (1) ES2055677T5 (no)
FI (1) FI102454B (no)
GR (1) GR900300093T1 (no)
IE (1) IE62587B1 (no)
NO (1) NO301046B1 (no)
NZ (1) NZ230400A (no)
SE (1) SE463851B (no)
WO (1) WO1990002545A1 (no)
ZA (1) ZA896681B (no)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
ATE173603T1 (de) * 1990-04-25 1998-12-15 Vivus Inc Behandlung von erektionversagen
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US20030181355A1 (en) * 1992-05-29 2003-09-25 Glenn Jeffrey S. Method for inhibition of viral infection
US5503973A (en) * 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
WO1996028142A1 (en) * 1995-03-14 1996-09-19 Vivus, Incorporated Method and kit for preventing erectile dysfunction
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
IT1292377B1 (it) 1997-06-19 1999-02-08 Nicox Sa Composizioni farmaceutiche a base di prostaglandine
IT1292426B1 (it) 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
JP2001509480A (ja) 1997-07-09 2001-07-24 アンドロソリューションズ,インク. 男性勃起機能不全を治療するための改良された方法及び組成物
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6200288B1 (en) 1997-08-26 2001-03-13 Queen's University At Kingston Everting toroid device for insertion into a body cavity
US5954688A (en) * 1997-08-26 1999-09-21 Queen's University At Kingston Everting toroid device for delivering a drug into a body cavity
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
EP1059926A2 (en) * 1997-12-18 2000-12-20 SCOTT, Nathan Earl PROSTAGLANDIN E 2?/F 2$g(a)? COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
EP1062508A1 (en) 1998-03-20 2000-12-27 The Rockefeller University Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6194433B1 (en) 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
US6132753A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
US6365590B1 (en) 1998-05-26 2002-04-02 Saint Louis University Compounds, compositions and methods for treating erectile dysfunction
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
US6482426B1 (en) 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
WO2000032195A1 (fr) * 1998-12-02 2000-06-08 Mochida Pharmaceutical Co., Ltd. Preparations destinees a etre administrees par voie uretrale
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
WO2000051978A1 (en) 1999-03-01 2000-09-08 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
US6613768B1 (en) 1999-04-30 2003-09-02 Lilly Icos Llc Treatment of female arousal disorder
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
AUPQ105799A0 (en) 1999-06-18 1999-07-08 Victor Chang Cardiac Research Institute, The Cell growth inhibition
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
US7223406B2 (en) 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
EP1404336A1 (en) * 2001-06-14 2004-04-07 Sampad Bhattacharya Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CN1203055C (zh) 2001-09-26 2005-05-25 朱德煦 治疗或预防细菌感染的方法和组合物
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
ES2431040T3 (es) * 2002-03-08 2013-11-22 Shanghai Institutes For Biological Sciences, Cas Detección y modulación de la angiogénesis mediada por Slit y Roundabout (Robo), y sus usos
CN100424175C (zh) 2002-03-26 2008-10-08 上海泽生科技开发有限公司 ErbB-3 用于肿瘤治疗的方法和组合物
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
KR20040043996A (ko) * 2002-11-20 2004-05-27 조나겐, 아이엔씨. 남성 발기부전치료를 위한 개선된 조성물
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
WO2011059586A2 (en) 2009-10-30 2011-05-19 The Regents Of The University Of Michigan Multifunctional small molecules
CN103228782B (zh) 2010-06-13 2016-03-30 中国科学院生物物理研究所 由干细胞制备心肌细胞的方法和组合物及其用途
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
US9402911B2 (en) 2011-12-08 2016-08-02 The Regents Of The University Of Michigan Multifunctional small molecules
CN107460164B (zh) 2012-07-23 2021-02-05 中国科学院生物物理研究所 体外诱导多能干细胞分化为心室肌细胞的方法
CN104884077B (zh) 2012-10-08 2019-02-12 上海泽生科技开发股份有限公司 治疗糖尿病患者心力衰竭的组份和方法
BR112015029293A2 (pt) 2013-05-22 2018-04-24 Zensun Shanghai Science & Tech Ltd método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero
CN113289002A (zh) 2020-02-24 2021-08-24 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0149254A3 (en) * 1983-12-29 1987-01-28 The Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing l-histidine
DE3637157A1 (de) * 1985-11-01 1987-05-21 Byk Gulden Lomberg Chem Fab Arzneimittel zur behandlung erektiler dysfunktionen
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
US5583144A (en) * 1995-02-24 1996-12-10 Kral; John G. Methods for treating erectile impotence

Also Published As

Publication number Publication date
EP0357581B2 (en) 1998-09-16
WO1990002545A1 (en) 1990-03-22
JPH0791199B2 (ja) 1995-10-04
FI102454B1 (fi) 1998-12-15
FI910976A0 (fi) 1991-02-27
SE463851B (sv) 1991-02-04
US5843961A (en) 1998-12-01
IE62587B1 (en) 1995-02-08
JPH04501707A (ja) 1992-03-26
US5886039A (en) 1999-03-23
ZA896681B (en) 1990-06-27
EP0357581A1 (en) 1990-03-07
FI102454B (fi) 1998-12-15
DK175560B1 (da) 2004-12-06
US5849803A (en) 1998-12-15
EP0432199A1 (en) 1991-06-19
NZ230400A (en) 1992-01-29
US5942512A (en) 1999-08-24
EP0432199B1 (en) 1993-07-28
NO910828L (no) 1991-04-30
DE68907909T3 (de) 2004-02-26
ES2055677T3 (es) 1994-11-01
GR900300093T1 (en) 1991-09-27
EP0432199B2 (en) 2003-07-30
SE8803087L (sv) 1990-03-03
DK36491A (da) 1991-03-01
CA1335346C (en) 1995-04-25
AU638414B2 (en) 1993-07-01
DE68907909D1 (de) 1993-09-02
NO301046B1 (no) 1997-09-08
ES2055677T5 (es) 1998-11-16
EP0357581B1 (en) 1993-07-28
DE68907909T2 (de) 1993-12-23
IE892680L (en) 1990-03-02
AU4199489A (en) 1990-04-02
SE8803087D0 (sv) 1988-09-02
DK36491D0 (da) 1991-03-01
ES2055677T1 (es) 1994-09-01

Similar Documents

Publication Publication Date Title
NO910828D0 (no) Preparat for behandling av erektil funksjonssvikt.
NO892936L (no) Fremgangsmaate for fremstilling av furanderivater.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO884052L (no) Fremgangsmaate for fremstilling av terapeutisk preparat.
NO885454L (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO890969L (no) Fremgangsmaate for fremstilling av isoindolinderivater.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO892204L (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO882893D0 (no) Fremgangsmaate for fremstilling av ureaformaldehydharpiks.
NO892561D0 (no) Fremgangsmaate for fremstilling av bindemidler.
NO893548D0 (no) Fremgangsmaate til fremstilling av fluorsubstituerte 4'-demetylepipodofyllotoksinglukosider.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO891588D0 (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO893794L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO893768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO892813L (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.
NO893796D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO893795L (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.

Legal Events

Date Code Title Description
MK1K Patent expired